Literature DB >> 12185607

The Tetrafigap Survey on the long-term outcome of tetraplegic spinal cord injured persons: Part III. Medical complications and associated factors.

R Klotz1, P A Joseph, J F Ravaud, L Wiart, M Barat.   

Abstract

STUDY
DESIGN: To study the short- and long-term medical complications encountered in tetraplegic spinal cord injured persons (TSCI) and to give prominence to both the medical and socio-economic factors with which they are respectively associated.
METHODS: The Tetrafigap Study is a multicentre epidemiological survey carried out using self-administered questionnaires studying the global long-term outcome of TSCI patients after the initial phase of rehabilitation.
RESULTS: The data for 1668 patients were analyzed. The rate of rehospitalizations was 74.4% with on average three stays per patient and as reported causes, in descending order: urinary complications, systematic follow-up, pressure sores, respiratory complications, contractures, bowel complications, pains and secondary fractures of the lower limbs. At the time of the survey, 84.7% of patients mentioned awkward contractures, 73.8% pains, 55.9% embarrassing urinary leakage and 14.1% pressure sores. With regard to persons suffering from complete motor lesion, urinary complications and pressure sores were more frequently reported, whereas for persons suffering from incomplete motor lesions, awkward contractures and pains were more frequent. In the elderly, pains were more often mentioned, and pressure sores and pain were also the most common in patients coming from lower socio-professional status. Contractures and pain decreased with time. All these complications but pressure sores and pain are statistically interrelated.
CONCLUSION: The medical complications of spinal cord injured persons are frequent, they are linked to biological, psychological and environmental factors, and are interrelated. Therefore, seeking mid- and long-term risk factors must be given priority in order to better adapt attempts at increasing secondary prevention.

Entities:  

Mesh:

Year:  2002        PMID: 12185607     DOI: 10.1038/sj.sc.3101317

Source DB:  PubMed          Journal:  Spinal Cord        ISSN: 1362-4393            Impact factor:   2.772


  8 in total

1.  Assessment of physical function and secondary complications after complete spinal cord injury.

Authors:  Shauna Dudley-Javoroski; Richard K Shields
Journal:  Disabil Rehabil       Date:  2006-01-30       Impact factor: 3.033

2.  Surgical restoration of arm and hand function in people with tetraplegia.

Authors:  Anne M Bryden; Allan E Peljovich; Harry A Hoyen; Gregory Nemunaitis; Kevin L Kilgore; Michael W Keith
Journal:  Top Spinal Cord Inj Rehabil       Date:  2012

3.  Prevalence and associated factors of pain in the Swiss spinal cord injury population.

Authors:  R Müller; M W G Brinkhof; U Arnet; T Hinrichs; G Landmann; X Jordan; M Béchir
Journal:  Spinal Cord       Date:  2016-11-15       Impact factor: 2.772

4.  Statewide investigation of medically attended adverse health conditions of persons with spinal cord injury.

Authors:  Elisabeth Pickelsimer; Eric J Shiroma; Dulaney A Wilson
Journal:  J Spinal Cord Med       Date:  2010       Impact factor: 1.985

5.  Factors associated with upper extremity contractures after cervical spinal cord injury: A pilot study.

Authors:  Dustin Hardwick; Anne Bryden; Gina Kubec; Kevin Kilgore
Journal:  J Spinal Cord Med       Date:  2017-06-05       Impact factor: 1.985

6.  Preliminary reliability and validity of a Spinal Cord Injury Secondary Conditions Scale.

Authors:  Claire Z Kalpakjian; William M Scelza; Martin B Forchheimer; Loren L Toussaint
Journal:  J Spinal Cord Med       Date:  2007       Impact factor: 1.985

7.  Obstacles to community participation among youth with spinal cord injury.

Authors:  Julie Gorzkowski; Erin H Kelly; Sara J Klaas; Lawrence C Vogel
Journal:  J Spinal Cord Med       Date:  2011-11       Impact factor: 1.985

8.  Survival Analysis in Patients with Chronic Traumatic Spinal Cord Injury.

Authors:  Mahsa Ghajarzadeh; Abbas Rahimi Foroushani; Saharnaz Nedjat; Abdolreza Sheikhrezaei; Hooshang Saberi
Journal:  Iran J Public Health       Date:  2019-12       Impact factor: 1.429

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.